Ownership history in Lindbrook Capital, LLC · 8 quarters on record
This page tracks every 13F SEC filing in which Lindbrook Capital, LLC reported a position in ESPERION THERAPEUTICS INC NEW COM (ESPR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2024 Q4 | UNCHANGED | 255 | — | 0% | 0.00% | $561 | $2.20 |
| 2024 Q3 | REDUCED | 255 | -570 | -69.1% | 0.00% | $421 | $1.65 |
| 2023 Q1 | REDUCED | 825 | -686 | -45.4% | 0.00% | $1K | $1.59 |
| 2022 Q4 | ADDED | 1,511 | +285 | +23.2% | 0.00% | $9K | $6.23 |
| 2022 Q3 | REDUCED | 1,226 | -22 | -1.8% | 0.00% | $8K | $6.70 |
| 2022 Q2 | REDUCED | 1,248 | -426 | -25.4% | 0.00% | $8K | $6.36 |
| 2022 Q1 | ADDED | 1,674 | +1,374 | +458.0% | 0.00% | $8K | $4.64 |
| 2019 Q1 | INITIATED | 300 | — | — | 0.00% | $12K | — |
As of 2025 Q4 — sorted by position size